Chemotherapy in Metastatic Nonanaplastic Thyroid Cancer: Experience at the Institut Gustave-Roussy
Open Access
- 1 October 1990
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 76 (5) , 480-483
- https://doi.org/10.1177/030089169007600513
Abstract
Forty-nine patients with metastatic nonanaplastic thyroid carcinoma were treated over a 10-year period. Five successive chemotherapeutic protocols were used: a combination of doxorubicin, etoposide, 5-fluorouracil and cyclophosphamide; elliptinium acetate; doxorubicin; cispiatin; and the combination of doxorubicin and cispiatin. Results obtained with the different protocols were very disappointing, with only two objective responses (3%). Phase II trials with new chemotherapeutic agents are warranted in selected cases of nonanaplastic metastatic thyroid carcinoma.This publication has 17 references indexed in Scilit:
- Aclarubicin in advanced thyroid cancer: a phase II studyEuropean Journal of Cancer and Clinical Oncology, 1988
- Chemotherapy for thyroid cancerRadiotherapy and Oncology, 1987
- Long-Term Results of Treatment of 283 Patients with Lung and Bone Metastases from Differentiated Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 1986
- Combination chemotherapy of metastatic thyroid cancerAmerican Journal of Clinical Oncology, 1983
- Medullary thyroid carcinoma: Prognostic factors and treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Adjunctive management of thyroid cancer: ChemotherapyJournal of Surgical Oncology, 1980
- Effects of radiotherapy on the bone marrow granulocytic progenitor cells (CFUc) of patients with malignant lymphomas—I: Short-term effectsInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Failure of Medullary Carcinoma of the Thyroid to Respond to Doxorubicin TherapyHormone Research, 1978
- A New Antitumoral Agent: 9-Hydroxyellipticine. Possibility of a Rational Design of Anticancerous Drugs in the Series of DNA Intercalating DrugsProceedings of the National Academy of Sciences, 1974
- Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumorsCancer, 1974